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Introduction
Diabetes mellitus may alter cardiac structure and
function independently of underlying coronary artery
disease or hypertension. This so called “diabetic cardio-
myopathy” is associated with myocardial fibrosis and is
characterized by a long and silent phase of progressive
left ventricular (LV) remodeling before the occurrence
of contractile dysfunction and heart failure symptoms.
In the preclinical stage, with normal LV ejection frac-
tion, new echocardiographic techniques reported subtle
myocardial dysfunction with a decrease in systolic strain.
Recently, myocardial T1 mapping has been proposed
to detect interstitial fibrosis early in the disease course.
Purpose
to evaluate whether myocardial T1 mapping could
detect abnormalities in type 2 diabetic patients with nor-
mal standard parameters of LV function and normal
LGE imaging.
Methods
Type 2 asymptomatic diabetic patients with no history
of heart disease, a normal LV assessed by conventional
echocardiography (normal LV volumes, ejection fraction
and wall motion) and normal LGE imaging were com-
pared to matched healthy volunteers.
T1 quantification was performed using a Modified
Look-Locker Inversion -recovery (MOLLI) sequence at
1.5T (Siemens), on a short axis of the LV, before, 5 and
15 min after 0.2 mmol/kg gadolinium injection. Imaging
protocol included also standard Cine-SSFP imaging, and
LGE imaging. Regional strains were assessed using Dis-
placement Encoding with Stimulated Echoes (DENSE)
imaging. Left ventricular diastolic function (mitral inflow
pattern) was further assessed using echocardiography.
Results
Twenty-four diabetic patients (51±4 years old) and 16
matched volunteers (47±7 years old) were included.
Despite normal ejection fraction, global circumferential
strain was decreased in diabetic patients compared to
volunteers (14.6±0.3 vs. 17.0±0.4 %, respectively,
p<0.05).
Mean myocardial T1 relaxation time was significantly
shorter in diabetic patients than in volunteers both at
5 (312±5 vs.361±6 milliseconds, respectively, p<0.001)
and 15 minutes (405±6 vs. 456±5 milliseconds, respec-
tively, p<0.001) after gadolinium injection.
Echocardiography displayed abnormal diastolic LV fill-
ing with an impaired LV relaxation in 55% of patients
and in 25% of volunteers. Interestingly, post-contrast
myocardial T1 time was shorter in case of impaired
relaxation than in case of normal mitral inflow pattern
(320±8 vs. 340±16 milliseconds, respectively, p=0.05).
Conclusions
T1 relaxation time is decreased in asymptomatic type 2
diabetic patients with normal ejection fraction. T1
abnormalities are associated with impaired myocardial
circumferential strain and early diastolic dysfunction
suggesting that interstitial fibrosis may be implicated in
diabetic cardiomyopathy. In the future, T1 quantification
may contribute to detect subclinical stage of diabetic
cardiomyopathy.
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